Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic
Shreya Patel, Misty Thompson, James E. Slaven, Don B. Sanders, Clement L. Ren
Abstract
To assess the impact of COVID-19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 versus 2020. Restrictions on social interaction due to the COVID-19 pandemic were associated with a lower number of PEx events at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.
Topics & Concepts
MedicineCystic fibrosisCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRespiratory systemRetrospective cohort studyPediatricsPulmonary fibrosisInternal medicineVirologyLungDiseaseOutbreakInfectious disease (medical specialty)Cystic Fibrosis Research AdvancesTracheal and airway disordersRespiratory viral infections research